Multidisciplinary Approach to Esophageal and Gastric Cancer

被引：27

作者：

Quiros, Roderick M. ^{[1
]}

Bui, Courtney L. ^{[1
]}

机构：

[1] St Lukes Hosp & Hlth Network, Bethlehem, PA 18015 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2009年 / 89卷 / 01期

关键词：

Esophageal cancer; Castric cancer; Surgery; Chemotherapy; Radiation therapy; Neoadjuvant; Adjuvant; PHASE-III TRIAL; SQUAMOUS-CELL CARCINOMA; ADVANCED ESOPHAGOGASTRIC CANCER; RANDOMIZED CONTROLLED-TRIAL; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; MINIMALLY INVASIVE ESOPHAGECTOMY; ENDOSCOPIC MUCOSAL RESECTION; POSITRON-EMISSION-TOMOGRAPHY; METASTATIC COLORECTAL-CANCER; COMBINED-MODALITY THERAPY;

D O I：

10.1016/j.suc.2008.09.019

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The incidence of esophageal and gastric malignancies has increased over the last decade. Historically, surgery has been considered the best treatment for these cancers. However, long-term survival after surgery is fair at best, because of the tendency of disease to recur locally and distantly. Presently, the management of these cancers involves surgery, chemotherapy, and radiation therapy. This article discusses various treatment strategies that employ these modalities either alone or in combination, in an attempt to improve survival rates for patients who have gastroesophageal malignancies.

引用

页码：79 / +

页数：19

共 93 条

[31] Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01 [J].

Fujitani, Kazumasa ;

Yang, Han-Kwang ;

Kurokawa, Yukinori ;

Park, Do Joong ;

Tsujinaka, Toshimasa ;

Park, Byung-Joo ;

Fukuda, Haruhiko ;

Noh, Sung Hoon ;

Boku, Narikazu ;

Bang, Yung-Jue ;

Sasako, Mitsuru ;

Lee, Jong-Inn .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) :504-506

[32] Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia [J].

Gammon, MD ;

Schoenberg, JB ;

Ahsan, H ;

Risch, HA ;

Vaughan, TL ;

Chow, WH ;

Rotterdam, H ;

West, AB ;

Dubrow, R ;

Stanford, JL ;

Mayne, ST ;

Farrow, DC ;

Niwa, S ;

Blot, WJ ;

Fraumeni, JF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1277-1284

[33] Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and princess Margaret hospital phase II consortia [J].

Garcia, Agustin A. ;

Hirte, Hal ;

Fleming, Gini ;

Yang, Dongyun ;

Tsao-Wei, Denice D. ;

Roman, Lynda ;

Groshen, Susan ;

Swenson, Steve ;

Markland, Frank ;

Gandara, David ;

Scudder, Sidney ;

Morgan, Robert ;

Chen, Helen ;

Lenz, Heinz-Josef ;

Oza, Amit M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) :76-82

[34] Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer [J].

García, I ;

Vizoso, F ;

Martín, A ;

Sanz, L ;

Abdel-Lah, O ;

Raigoso, P ;

García-Muñiz, JL .

ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (03) :234-241

[35] Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis [J].

Gebski, Val ;

Burmeister, Bryan ;

Smithers, B. Mark ;

Foo, Kerwyn ;

Zalcberg, John ;

Simes, John .

LANCET ONCOLOGY, 2007, 8 (03) :226-234

[36] ADENOCARCINOMA OF THE STOMACH - AREAS OF FAILURE IN A REOPERATION SERIES (2ND OR SYMPTOMATIC LOOK) CLINICOPATHOLOGIC CORRELATION AND IMPLICATIONS FOR ADJUVANT THERAPY [J].

GUNDERSON, LL ;

SOSIN, H .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (01) :1-11

[37] THE 2ND BRITISH STOMACH-CANCER GROUP TRIAL OF ADJUVANT RADIOTHERAPY OR CHEMOTHERAPY IN RESECTABLE GASTRIC-CANCER - 5-YEAR FOLLOW-UP [J].

HALLISSEY, MT ;

DUNN, JA ;

WARD, LC ;

ALLUM, WH ;

ARNOTT, S ;

BAKER, P ;

BROOKES, VS ;

CRAVEN, JL ;

ELLIS, DJ ;

FIELDING, JWL ;

FAGG, SL ;

HOCKEY, MS ;

LEVISON, D ;

JONES, BG ;

KELLY, K ;

MASON, MC ;

MINAWA, A ;

MCADAM, A ;

TIMOTHY, A ;

WATERHOUSE, JAH ;

WINSEY, S ;

WRIGLEY, PFM .

LANCET, 1994, 343 (8909) :1309-1312

[38] Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial [J].

Hartgrink, HH ;

van de Velde, CJH ;

Putter, H ;

Bonenkamp, JJ ;

Kranenbarg, EK ;

Songun, I ;

Welvaart, K ;

van Krieken, JHJM ;

Meijer, S ;

Plukker, JTM ;

van Elk, PJ ;

Obertop, H ;

Gouma, DJ ;

van Lanschot, JJB ;

Taat, CW ;

de Graaf, PW ;

von Meyenfeldt, MF ;

Tilanus, H ;

Sasako, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2069-2077

[39] COMBINED CHEMOTHERAPY AND RADIOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN PATIENTS WITH CANCER OF THE ESOPHAGUS [J].

HERSKOVIC, A ;

MARTZ, K ;

ALSARRAF, M ;

LEICHMAN, L ;

BRINDLE, J ;

VAITKEVICIUS, V ;

COOPER, J ;

BYHARDT, R ;

DAVIS, L ;

EMAMI, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (24) :1593-1598

[40] Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: Results of the TREE study [J].

Hochster, Howard S. ;

Hart, Lowell L. ;

Ramanathan, Ramesh K. ;

Childs, Barrett H. ;

Hainsworth, John D. ;

Cohn, Allen L. ;

Wong, Lucas ;

Fehrenbacher, Louis ;

Abubakr, Yousif ;

Saif, M. Wasif ;

Schwartzberg, Lee ;

Hedrick, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3523-3529

← 1 2 3 4 5 6 7 8 9 10 →